跳至主要内容
临床试验/NCT06688201
NCT06688201招募中不适用

Minimally Invasive Soft Channel Brain Haemorrhage Evacuation for Acute Basal Ganglia Haemorrhage-- Large Hemorrhage Evacuation (MIRACLE-L)

Capital Medical University1 个研究点 分布在 1 个国家目标入组 550 人开始时间: 2025年1月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
550
试验地点
1
主要终点
The primary outcome is death or major disability (mRS scores 0-3) at 6 months.

研究概览

简要总结

To determine if minimally invasive soft channel brain hemorrhage evacuation (scMIS), compared with any other neurosurgical technique that includes open craniotomy, small skull window microsurgery , and endoscopic surgery, is at least as effective ('not inferior') on poor clinical outcome of death or major disability (mRS scores 4-6) at 6 months in basal ganglia intracerebral hemorrhage (ICH) of 30 < volume ≤ 100 ml.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion Criteria:
  • Adults (18 - 80 years) ;
  • The clinical diagnosis is acute intracerebral hemorrhage, confirmed by imaging;
  • Onset within 48 hours, and surgery can be initiated within 48 hours;
  • Basal ganglia hemorrhage, with a bleeding volume of 30 < volume ≤ 100 ml;
  • Reduced level of consciousness (GCS 4-14);
  • Pre-stroke mRS score≤1 points;
  • Systolic blood pressure <140 mmHg before randomisation;
  • Availability of being able to receive either scMIS or other neurosurgical technique;
  • Informed consent obtain accordingly to local regulations.

排除标准

  • Definite evidence the ICH is secondary to a structural abnormality in the brain (eg arteriovenous malformation, intracranial aneurysm, tumour, trauma, cerebral venous thrombosis) or previous thrombolysis or neurointerventional surgery.
  • A high likelihood that the patient will not adhere to the study treatment and follow-up regimen.
  • Platelet count < 100,000, INR > 1.4.

结局指标

主要结局

The primary outcome is death or major disability (mRS scores 0-3) at 6 months.

时间窗: 6 months after randomization

Ordinal analysis of modified Rankin Scale \[mRS\] score: 0 =No symptoms at all.1 =No significant disability despite symptoms, able to carry out all usual duties and activities.2 =Slight disability, unable to carry out all previous activities but able to look after own affairs without assistance.3 =Moderate disability requiring some help, but able to walk without Assistance. 4 =Moderate severe disability, unable to walk without assistance and unable to attend to own bodily needs without assistance.5 =Severe disability, bedridden incontinent, and requiring constant nursing care and attention.6 =Dead.

次要结局

  • Discharge at Day 7 (yes vs. no)(7 days after randomization)
  • Total length of intensive care unit stay(During hospitalisation up to 6 months after randomization)
  • Ordinal analysis of modified Rankin Scale [mRS] scores at 28 days(28 days after randomization)
  • The following at 6-months: ordinal analysis of modified Rankin Scale [mRS] scores 3-6(6-months after randomization)
  • The following at 6-months: ordinal analysis of modified Rankin Scale [mRS] scores 3-5(6-months after randomization)
  • The following at 6-months: ordinal analysis of modified Rankin Scale [mRS] scores 0-6(6-months after randomization)
  • The following at 6-months: AMC Linear Disability Score(ALDs)(6-months after randomization)
  • The following at 6-months: EuroQoL Group 5-Dimension self-report questionnaire (EQ-5D)(6-months after randomization)
  • Days of hospitalization(During hospitalisation up to 6 months after randomization)

研究者

发起方
Capital Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ji Xunming,MD,PhD

Professor ,Beijing Institute of Brain Disorders,Captial Medcial University

Capital Medical University

研究点 (1)

Loading locations...

相似试验